There was no signal in favor of rituximab [vs azathioprine] even in patients at high risk for vasculitis relapse,’ said Xavier Puéchal, MD, PhD.

Asthma may not be driven by the molecules scientists have blamed for decades. Researchers have identified “pseudo leukotrienes,” inflammation-triggering compounds formed by uncontrolled free-radical ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

In the Motor City, it’s more than just vehicle exhaust causing problems for people living with asthma. While pollution from vehicle emissions and manufacturing plays a role in exacerbating the ...

When your child has asthma, an asthma action plan can help you respond quickly to symptoms and prevent emergency department visits and hospitalizations. “An asthma action plan … outlines which ...

Stephen Hughes receives research grant funding from the Australian Government Department of Health and Aged Care Medical Research Future Fund, The Australian Research Council and Asthma Australia. He ...

Background Obesity is associated with more severe asthma, however, the mechanisms responsible are poorly understood. Obesity is also associated with low-grade systemic inflammation; it is possible ...

Correspondence to Cecilie Skaarup Uldbjerg, Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus 8000, Denmark; cecilie{at}uldbjerg.com Objective To investigate ...

New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases. Current asthma treatments don't work in all patients, and they ...

Asthma is a heterogeneous condition that is characterized by reversible airway obstruction. Childhood-onset asthma (COA) and adult-onset asthma (AOA) are two prominent asthma subtypes, each with ...